The fact that the trial continued without change is an indication of efficacy. They cant just release data on an ongoing trial. Completely compromises the concept of a double blind. You cant have both patient and doctor expecting result 'x'.
They wont get to 50 cents for another 12 months at least to make that the spp. They need funding now, we arent the only ones targeting 11bhsd so we have to beat the competition to these other indications, and we have to prepare for phase three for a rapid transition upon positive phase two results.
ACW Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
